Keith Zullow is a partner in the firm’s Litigation Department, where he focuses on intellectual property litigation. Mr. Zullow has had significant experience in chemical and pharmaceutical litigation, interference practice, and trade secret litigation. Mr. Zullow has worked on cases in various federal district courts throughout the United States, and on appeals before the U.S. Court of Appeals for the Federal Circuit and other circuit courts.

Professional Experience

Before joining Goodwin Procter, Mr. Zullow was an associate at Fish & Neave, where his work focused on intellectual property litigation, trade secret litigation, interference practice and patent prosecution for clients including ExxonMobil Chemical Company, Hoechst Celanese, Aventis Pharmaceuticals, The Gillette Company, and Phelps Dodge. Since joining the firm, Mr. Zullow has focused on pharmaceutical and chemical patent litigation and client counseling. In this capacity, he has helped Inverness Medical Innovations, Inc. obtain a favorable Federal Circuit ruling that reversed an unfavorable claim construction; has helped Inverness to obtain preliminary injunctions against potentially infringing products; and has helped Teva Pharmaceuticals USA, Inc. to obtain summary judgments of non-infringement regarding two different pharmaceutical products.

Bar and Court Admissions

Mr. Zullow is a member of the New York State bar, the Southern and Eastern Districts of New York, and the U.S. Court of Appeals for the Federal Circuit. He is also admitted to practice before the U.S. Patent and Trademark Office.

Education

J.D., New York University School of Law, 1994
B.S., Chem. Engr., Cornell University, 1987 (with distinction)